7.8-7.14 | 临床研究顶刊快报
文摘
教育
2024-07-15 10:08
中国香港
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
1. Perkovic V, Tuttle KR, Rossing P, Mahaffey KW, Mann JFE, Bakris G, et al. Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes. New England Journal of Medicine. 2024;391(2):109-21.2. Mayer KA, Schrezenmeier E, Diebold M, Halloran PF, Schatzl M, Schranz S, et al. A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection. New England Journal of Medicine. 2024;391(2):122-32.3. Asselah T, Chulanov V, Lampertico P, Wedemeyer H, Streinu-Cercel A, Pântea V, et al. Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D. New England Journal of Medicine. 2024;391(2):133-43.4. Assad Z, Romain A-S, Aupiais C, Shum M, Schrimpf C, Lorrot M, et al. Nirsevimab and Hospitalization for RSV Bronchiolitis. New England Journal of Medicine. 2024;391(2):144-54.5. Deschamps A, Ben Abdallah A, Jacobsohn E, Saha T, Djaiani G, El-Gabalawy R, et al. Electroencephalography-Guided Anesthesia and Delirium in Older Adults After Cardiac Surgery: The ENGAGES-Canada Randomized Clinical Trial. JAMA. 2024;332(2):112-23.6. Chua K-P, Conti RM, Lagisetty P, Bohnert AS, He S, Nguyen TD. Association Between Cost Sharing and Naloxone Prescription Dispensing. JAMA. 2024;332(2):124-32.7. Karthikeyan G, Ntsekhe M, Islam S, Rangarajan S, Avezum A, Benz A, et al. Mortality and Morbidity in Adults With Rheumatic Heart Disease. JAMA. 2024;332(2):133-40.8. Kelly P, Lemmens R, Weimar C, Walsh C, Purroy F, Barber M, et al. Long-term colchicine for the prevention of vascular recurrent events in non-cardioembolic stroke (CONVINCE): a randomised controlled trial. The Lancet. 2024;404(10448):125-33.9. Pocovi NC, Lin C-WC, French SD, Graham PL, van Dongen JM, Latimer J, et al. Effectiveness and cost-effectiveness of an individualised, progressive walking and education intervention for the prevention of low back pain recurrence in Australia (WalkBack): a randomised controlled trial. The Lancet. 2024;404(10448):134-44.10. Adler AI, Coleman RL, Leal J, Whiteley WN, Clarke P, Holman RR. Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91). The Lancet. 2024;404(10448):145-55.11. Sackley CM, Rick C, Brady MC, Woolley R, Burton C, Patel S, et al. Lee Silverman voice treatment versus NHS speech and language therapy versus control for dysarthria in people with Parkinson’s disease (PD COMM): pragmatic, UK based, multicentre, three arm, parallel group, unblinded, randomised controlled trial. BMJ. 2024;386:e078341.12. Zhu S, Sinha D, Kirk M, Michalopoulou M, Hajizadeh A, Wren G, et al. Effectiveness of behavioural interventions with motivational interviewing on physical activity outcomes in adults: systematic review and meta-analysis. BMJ. 2024;386:e078713.部分文字参考新英格兰医学前沿。
